IWC
LXRX icon

Integrated Wealth Concepts’s Lexicon Pharmaceuticals LXRX Stock Holding History

Integrated Wealth Concepts’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,210
Closed -$15.3K – 2051
2025
Q2 		$15.3K Buy
+16,210
New +$10.5K ﹤0.01% 1891

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Integrated Wealth Concepts's LXRX Position: Q3 2025 in Review

Integrated Wealth Concepts sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2025, closing a stake of 16,210 shares — an estimated $15.3K sold.

Integrated Wealth Concepts first reported a position in LXRX in Q2 2025 and held it in 1 quarter. The position peaked at $15.3K in Q2 2025. 123 funds tracked by Wall St. Rank hold LXRX as of Q3 2025.

  • Integrated Wealth Concepts reported no remaining Lexicon Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Integrated Wealth Concepts sold 16,210 Lexicon Pharmaceuticals shares in Q3 2025, an estimated $15.3K.
  • Integrated Wealth Concepts first reported a position in Lexicon Pharmaceuticals in Q2 2025 and held it in 1 quarter.
  • Integrated Wealth Concepts's Lexicon Pharmaceuticals position peaked at $15.3K in Q2 2025.
  • 123 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2025.

Based on Integrated Wealth Concepts's 13F filing for Q3 2025, filed 14 Nov 2025.